In summary, our study reveals that the SMARCA4-R1157W mutation accelerates the progression of CRC by increasing the SMARCA4 binding to PRMT1-mediated H4R3me2a and enhancing ATPase activity and chromatin remodeling activities. Here, PRMT1 is linked to colorectal carcinoma.